BCTXZ vs REG
BriaCell Therapeutics Corp. Warrant (BCTXZ) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
BriaCell Therapeutics Corp. Warrant (BCTXZ) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
BCTXZ does not have a complete income-statement cache yet.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
BCTXZ currently screens at market cap $0. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the BCTXZ and REG stock pages for the full models.
Not investment advice.